1. Home
  2. BCYC vs PINC Comparison

BCYC vs PINC Comparison

Compare BCYC & PINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • PINC
  • Stock Information
  • Founded
  • BCYC 2009
  • PINC 2013
  • Country
  • BCYC United Kingdom
  • PINC United States
  • Employees
  • BCYC N/A
  • PINC N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • PINC Other Consumer Services
  • Sector
  • BCYC Health Care
  • PINC Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • PINC Nasdaq
  • Market Cap
  • BCYC 1.7B
  • PINC 1.9B
  • IPO Year
  • BCYC 2019
  • PINC 2013
  • Fundamental
  • Price
  • BCYC $15.59
  • PINC $21.58
  • Analyst Decision
  • BCYC Buy
  • PINC Hold
  • Analyst Count
  • BCYC 9
  • PINC 7
  • Target Price
  • BCYC $36.00
  • PINC $21.42
  • AVG Volume (30 Days)
  • BCYC 880.7K
  • PINC 692.9K
  • Earning Date
  • BCYC 10-31-2024
  • PINC 02-03-2025
  • Dividend Yield
  • BCYC N/A
  • PINC 3.98%
  • EPS Growth
  • BCYC N/A
  • PINC N/A
  • EPS
  • BCYC N/A
  • PINC 1.32
  • Revenue
  • BCYC $36,898,000.00
  • PINC $1,325,477,000.00
  • Revenue This Year
  • BCYC $40.52
  • PINC N/A
  • Revenue Next Year
  • BCYC N/A
  • PINC $1.78
  • P/E Ratio
  • BCYC N/A
  • PINC $15.95
  • Revenue Growth
  • BCYC 48.60
  • PINC 2.65
  • 52 Week Low
  • BCYC $12.17
  • PINC $17.96
  • 52 Week High
  • BCYC $28.67
  • PINC $23.56
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 37.83
  • PINC 42.09
  • Support Level
  • BCYC $12.17
  • PINC $21.05
  • Resistance Level
  • BCYC $21.50
  • PINC $21.95
  • Average True Range (ATR)
  • BCYC 1.36
  • PINC 0.42
  • MACD
  • BCYC -0.36
  • PINC -0.17
  • Stochastic Oscillator
  • BCYC 49.67
  • PINC 17.09

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

About PINC Premier Inc.

Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.

Share on Social Networks: